Dan Horner’s Difficult Airway Society 2021 talk examines emergency airway management through three priorities: cardiovascular stability, oxygenation and first-pass success. The transcript connects the evidence with preparation, multidisciplinary teamwork and local systems that support safer care across departments.
Learning from airway management in the ED: UK Perspective Read More
An August 2021 appraisal of therapeutic-dose heparin in hospitalised COVID-19 patients without ICU-level organ support. It examines the multiplatform trial’s benefits, bleeding-risk exclusions and composite outcome, and explains why these findings differ from those in critically ill patients.
JC: Thromboprophylaxis for the non ICU hospitalised COVID-19 patient. St Emlyn’s Read More
An April 2021 discussion of post-vaccination headache as evidence about vaccine-induced thrombosis and thrombocytopenia was emerging. It explores VITT, cerebral venous sinus thrombosis and the role of clinical probability, targeted investigation and specialist input, reflecting the uncertainties and guidance available at that time.
Post-vaccine headache in the Emergency Department: what you need to know. St Emlyn’s Read More
Dan Horner takes a detailed look at the February 2021 RECOVERY tocilizumab preprint. The appraisal examines reported survival benefits alongside patient selection, incomplete follow-up, absolute versus relative effects and the uncertainties that remained behind the optimistic headlines.
Tocilizumabulous? A special offer on IL-6 with Tocilizumab. Read More
A January 2021 appraisal of REMAP-CAP’s early tocilizumab and sarilumab findings in critically ill patients with COVID-19. Dan Horner examines organ support and survival outcomes, strict eligibility criteria and the uncertainties that remained as the results moved rapidly into policy and public discussion.
Tocilizumorelikeit? The latest data on Tocilizumab. St Emlyn’s Read More
Before the fuller tocilizumab trial reports, Dan Horner examined the conflicting evidence available in December 2020. This appraisal considers biological plausibility, early REMAP-CAP announcements, adverse effects and the difficulty of discussing an experimental treatment when media coverage runs ahead of the data.
Tocilizumaybe? Immune modulation in COVID-19 Read More
How should trainee experience shape emergency medicine research priorities? Rob Hirst describes TERN’s 2020 priority-setting project, explains the Delphi consensus process and considers why the questions trainees encounter may differ from those emphasised by other professional groups.
Research, trainees and prioritisation in UK emergency medicine. Read More
Dan Horner revisits the evidence on venous thromboembolism in COVID-19 as it stood in October 2020. The review examines how screening and case selection affect reported clot rates, the distinction between different thrombotic findings, and uncertainty around risk prediction and higher-dose anticoagulation.
VTE and COVID-19: Would you like to know more? Read More
